The development of Hecaghen introduced muscle building to a new frontier in GH science. The MuscleMeds research and development team has made the leap into a new territory of muscle cell hyperplasia and muscle activation through the utilization of a unique combination of highly specialized actives, which includes a scientifically validated amino Hexapeptide. GHRP-2 Amino Hexapeptide and unique compounds that have the ability to help inhibit IGFBP-3. When taken at night, these compounds can help induce a deep anabolic sleep to accelerate muscle growth and stimulate fat burning metabolism.
These advanced compounds are administered in a patent pending FastSorb tablet delivery. The FastSorb tablet provides oral mucosal delivery, which allows for these compounds to be better absorbed – thereby preserving their activity as an anabolic activator. Hexaghen is still an exciting muscle building breakthrough even after four years on the market.
The development of Hexaghen, a unique orally effective IGF-1 activator, is going to help breed a new generation of top-level bodybuilders. Science shows that the benefits of improved GH and IGF-1 can be a “holy grail” to muscular growth. They pose highly anabolic actions and are critical mediators of muscle growth as they have the ability to help stimulate both the differentiation and proliferation of myoblasts (muscle cells). In general terminology, this means they have the unique ability to benefit not only the size but also the number of muscle cells. IGF-1 produced in the body also enhances muscle growth by increasing amino acid uptake and protein synthesis.
Through the development of Hexaghen, you can experience the anabolic promoting effects by boosting your IGF-1 levels. Hexaghen’s threshold IGF-1 output can help promote anabolic muscle cell hyperplasia and stimulate muscle cell growth.
Hexaghen’s efficacy is made possible through the utilization of a unique combination of highly specialized actives, which include: an amino Hexapeptide, GHRP-2 Amino Hexapeptide and the botanical based compounds cis -4, 17(20)-pregnadiene-3,16-dione, and trans-4, 17(20)-pregnadiene-3,16-dione, administered in a unique and FastSorb tablet delivery.
Active8 Nutrition will not be held responsible for any product information, statements, ingredients, or any ingredient changes of this product, or any product our company carries.